Application of Nanotechnology in Diagnosis and Therapeutics
439
Pankhurst QA, Connolly J, Jones S, Dobson J (2003) Applications of magnetic nanoparticles in
biomedicine. J Phys D Appl Phys 36:R167
Park JS et al (2006) N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for
intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release
115:37–45
Patel J, Garala K, Basu B, Raval M, Dharamsi A (2011) Solubility of aceclofenac in polyamidoamine
dendrimer solutions. Int J Pharm Investig 1:135–138
Patil S, Lalani R, Bhatt P, Vhora I, Patel V, Patel H, Misra A (2018) Hydroxyethyl substituted
linear polyethylenimine for safe and efficient delivery of siRNA therapeutics RSC. Advances
8:35461–35473
Patil S, Sandberg A, Heckert E, Self W, Seal S (2007) Protein adsorption and cellular uptake of
cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28:4600–4607
Perez EA (2009) Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance
to anthracyclines and taxanes in metastatic breast cancer. Breast Cancer Res Treat 114:195
Plank C, Mechtler K, Szoka FC Jr, Wagner E (1996) Activation of the complement system by
synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther
7:1437–1446
Price CF et al (2011) SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity
following vaginal administration in humans. PLoS One 6:e24095
Prokop A, Davidson JM (2008) Nanovehicular intracellular delivery systems. J Pharm Sci 97:3518–
3590
Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F (2006) Nanoencapsulation I. Methods for preparation of
drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2:8–21
Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V (1985) Amplification of P-glycoprotein
genes in multidrug-resistant mammalian cell lines. Nature 316:817–819
Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C (2011) Neurotherapeutic applications
of nanoparticles in Alzheimer’s disease. J Control Release 152:208–231
Sánchez-López E et al (2018) Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s
disease: in vitro and in vivo characterization. J Nanobiotechnol 16:32
Schliecker G, Schmidt C, Fuchs S, Kissel T (2003) Characterization of a homologous series of D,
L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. Biomaterials
24:3835–3844
Shah M, Naseer MI, Choi MH, Kim MO, Yoon SC (2010) Amphiphilic PHA–mPEG copolymeric
nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. Int J Pharm
400:165–175
Siegel SJ, Kahn JB, Metzger K, Winey KI, Werner K, Dan N (2006) Effect of drug type on the
degradation rate of PLGA matrices. Eur J Pharm Biopharm 64:287–293
Song X et al (2008) PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm
350:320–329
Staples M, Daniel K, Cima MJ, Langer R (2006) Application of micro-and nano-electromechanical
devices to drug delivery. Pharm Res 23:847–863
Sung S-J, Min SH, Cho KY, Lee S, Min Y-J, Yeom YI, Park J-K (2003) Effect of polyethylene
glycol on gene delivery of polyethylenimine. Biol Pharm Bull 26:492–500
Tang G et al (2003) Polyethylene glycol modified polyethylenimine for improved CNS gene transfer:
effects of PEGylation extent. Biomaterials 24:2351–2362
Tang X, Liang Y, Feng X, Zhang R, Jin X, Sun L (2015) Co-delivery of docetaxel and Poloxamer
235 by PLGA–TPGS nanoparticles for breast cancer treatment. Mater Sci Eng C 49:348–355
Thomas M et al (2012) PEI-complexed LNA antiseeds as miRNA inhibitors. RNA Biol 9:1088–1098
Thomas TP, Goonewardena SN, Majoros IJ, Kotlyar A, Cao Z, Leroueil PR, Baker JR Jr (2011)
Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis
Rheum 63:2671–2680
439
Pankhurst QA, Connolly J, Jones S, Dobson J (2003) Applications of magnetic nanoparticles in
biomedicine. J Phys D Appl Phys 36:R167
Park JS et al (2006) N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for
intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release
115:37–45
Patel J, Garala K, Basu B, Raval M, Dharamsi A (2011) Solubility of aceclofenac in polyamidoamine
dendrimer solutions. Int J Pharm Investig 1:135–138
Patil S, Lalani R, Bhatt P, Vhora I, Patel V, Patel H, Misra A (2018) Hydroxyethyl substituted
linear polyethylenimine for safe and efficient delivery of siRNA therapeutics RSC. Advances
8:35461–35473
Patil S, Sandberg A, Heckert E, Self W, Seal S (2007) Protein adsorption and cellular uptake of
cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28:4600–4607
Perez EA (2009) Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance
to anthracyclines and taxanes in metastatic breast cancer. Breast Cancer Res Treat 114:195
Plank C, Mechtler K, Szoka FC Jr, Wagner E (1996) Activation of the complement system by
synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther
7:1437–1446
Price CF et al (2011) SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity
following vaginal administration in humans. PLoS One 6:e24095
Prokop A, Davidson JM (2008) Nanovehicular intracellular delivery systems. J Pharm Sci 97:3518–
3590
Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F (2006) Nanoencapsulation I. Methods for preparation of
drug-loaded polymeric nanoparticles. Nanomed Nanotechnol Biol Med 2:8–21
Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V (1985) Amplification of P-glycoprotein
genes in multidrug-resistant mammalian cell lines. Nature 316:817–819
Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C (2011) Neurotherapeutic applications
of nanoparticles in Alzheimer’s disease. J Control Release 152:208–231
Sánchez-López E et al (2018) Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s
disease: in vitro and in vivo characterization. J Nanobiotechnol 16:32
Schliecker G, Schmidt C, Fuchs S, Kissel T (2003) Characterization of a homologous series of D,
L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. Biomaterials
24:3835–3844
Shah M, Naseer MI, Choi MH, Kim MO, Yoon SC (2010) Amphiphilic PHA–mPEG copolymeric
nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. Int J Pharm
400:165–175
Siegel SJ, Kahn JB, Metzger K, Winey KI, Werner K, Dan N (2006) Effect of drug type on the
degradation rate of PLGA matrices. Eur J Pharm Biopharm 64:287–293
Song X et al (2008) PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm
350:320–329
Staples M, Daniel K, Cima MJ, Langer R (2006) Application of micro-and nano-electromechanical
devices to drug delivery. Pharm Res 23:847–863
Sung S-J, Min SH, Cho KY, Lee S, Min Y-J, Yeom YI, Park J-K (2003) Effect of polyethylene
glycol on gene delivery of polyethylenimine. Biol Pharm Bull 26:492–500
Tang G et al (2003) Polyethylene glycol modified polyethylenimine for improved CNS gene transfer:
effects of PEGylation extent. Biomaterials 24:2351–2362
Tang X, Liang Y, Feng X, Zhang R, Jin X, Sun L (2015) Co-delivery of docetaxel and Poloxamer
235 by PLGA–TPGS nanoparticles for breast cancer treatment. Mater Sci Eng C 49:348–355
Thomas M et al (2012) PEI-complexed LNA antiseeds as miRNA inhibitors. RNA Biol 9:1088–1098
Thomas TP, Goonewardena SN, Majoros IJ, Kotlyar A, Cao Z, Leroueil PR, Baker JR Jr (2011)
Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis
Rheum 63:2671–2680